Turning Point Therapeutics, Inc.
TPTXDelisted Aug 17, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595893
Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Turning Point Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- +4 vs. Q2 2021
- Shares held
- 44.8M
- −32.1K (−0.1%) vs. Q2 2021
- Total value
- $2.98B
- −$516.6M (−14.8%) vs. Q2 2021
- New holders
- 24
- 69 more added
- Sold out
- 20
- 67 more reduced
3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 209 | $3.29B |
| Q1 2022 | 154 | $1.23B |
| Q4 2021 | 172 | $2.15B |
| Q3 2021 | 191 | $2.98B |
| Q2 2021 | 190 | $3.59B |
| Q1 2021 | 202 | $4.21B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Turning Point Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −4,762−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −3,647−100.0% | Sold out |
| Stonnington Group, LLC | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Burrage Capital Management LLC | 0 | $0 | 0.00% | −2,164−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −907−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −792−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −372−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Bartlett & Co. Wealth Management LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Bartlett & Co. LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |
| QS Investors, LLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |